At the National Community Oncology Dispensing Association(NCODA) 2017 Fall Summit, Michael Broderson, PharmD, discusses the importance of perseverance when managing cancer therapies in patients.
At theNational Community Oncology Dispensing Association2017 Fall Summit, Michael Broderson, PharmD, discussed how perserverance is important in maintaining a patient-centered approach to cancer care. When treating oncology patients, it is crucial for health care providers to be fully engaged in managing their patients' therapies and the treatment process from start to finish.
FDA Approves Omalizumab to Reduce Food-Based Allergic Reactions in Adult and Pediatric Patients
February 21st 2024This marks omalizumab’s fourth FDA-approved indication for allergic and inflammatory conditions, such as severe persistent allergic asthma, with its initial approval being in 2003.